Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Neurodevelopmental Disorders Caused by De Novo Variants in KCNB1 Genotypes and Phenotypes

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Association Between Sumatriptan Treatment During a Migraine Attack and Central 5-HT1B Receptor Binding

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. The first step towards personalized risk prediction for common epilepsies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The ARID1B spectrum in 143 patients: from nonsyndromic intellectual disability to Coffin-Siris syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Carolien G F de Kovel
  • Steffen Syrbe
  • Eva H Brilstra
  • Nienke Verbeek
  • Bronwyn Kerr
  • Holly Dubbs
  • Allan Bayat
  • Sonal Desai
  • Sakkubai Naidu
  • Siddharth Srivastava
  • Hande Cagaylan
  • Uluc Yis
  • Carol Saunders
  • Martin Rook
  • Susanna Plugge
  • Hiltrud Muhle
  • Zaid Afawi
  • Karl-Martin Klein
  • Vijayakumar Jayaraman
  • Ramakrishnan Rajagopalan
  • Ethan Goldberg
  • Eric Marsh
  • Sudha Kessler
  • Christina Bergqvist
  • Laura K Conlin
  • Bryan L Krok
  • Isabelle Thiffault
  • Manuela Pendziwiat
  • Ingo Helbig
  • Tilman Polster
  • Ingo Borggraefe
  • Johannes R Lemke
  • Marie-José van den Boogaardt
  • Rikke Steensbjerre Møller
  • Bobby P C Koeleman
Vis graf over relationer

Importance: Knowing the range of symptoms seen in patients with a missense or loss-of-function variant in KCNB1 and how these symptoms correlate with the type of variant will help clinicians with diagnosis and prognosis when treating new patients.

Objectives: To investigate the clinical spectrum associated with KCNB1 variants and the genotype-phenotype correlations.

Design, Setting, and Participants: This study summarized the clinical and genetic information of patients with a presumed pathogenic variant in KCNB1. Patients were identified in research projects or during clinical testing. Information on patients from previously published articles was collected and authors contacted if feasible. All patients were seen at a clinic at one of the participating institutes because of presumed genetic disorder. They were tested in a clinical setting or included in a research project.

Main Outcomes and Measures: The genetic variant and its inheritance and information on the patient's symptoms and characteristics in a predefined format. All variants were identified with massive parallel sequencing and confirmed with Sanger sequencing in the patient. Absence of the variant in the parents could be confirmed with Sanger sequencing in all families except one.

Results: Of 26 patients (10 female, 15 male, 1 unknown; mean age at inclusion, 9.8 years; age range, 2-32 years) with developmental delay, 20 (77%) carried a missense variant in the ion channel domain of KCNB1, with a concentration of variants in region S5 to S6. Three variants that led to premature stops were located in the C-terminal and 3 in the ion channel domain. Twenty-one of 25 patients (84%) had seizures, with 9 patients (36%) starting with epileptic spasms between 3 and 18 months of age. All patients had developmental delay, with 17 (65%) experiencing severe developmental delay; 14 (82%) with severe delay had behavioral problems. The developmental delay was milder in 4 of 6 patients with stop variants and in a patient with a variant in the S2 transmembrane element rather than the S4 to S6 region.

Conclusions and Relevance: De novo KCNB1 missense variants in the ion channel domain and loss-of-function variants in this domain and the C-terminal likely cause neurodevelopmental disorders with or without seizures. Patients with presumed pathogenic variants in KCNB1 have a variable phenotype. However, the type and position of the variants in the protein are (imperfectly) correlated with the severity of the disorder.

OriginalsprogEngelsk
TidsskriftArchives of Neurology
Vol/bind74
Udgave nummer10
Sider (fra-til)1228-1236
ISSN2168-6149
DOI
StatusUdgivet - 1 okt. 2017

ID: 51525907